United States - English - NLM (National Library of Medicine)

bryant ranch prepack - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mmhg or to 90 mmhg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Malta - English - Medicines Authority

yes pharmaceutical development services gmbh basler straße 7 61352 bad homburg , germany - tablet - minoxidil 2.5 mg - antihypertensives

Malta - English - Medicines Authority

yes pharmaceutical development services gmbh basler straße 7 61352 bad homburg , germany - tablet - minoxidil 10 mg - antihypertensives

Malta - English - Medicines Authority

poa pharma scandinavia ab hyllie stationstorg 31, vån 5, 215 32 malmö, sweden - tablet - minoxidil 2.5 mg - antihypertensives

Malta - English - Medicines Authority

poa pharma scandinavia ab hyllie stationstorg 31, vån 5, 215 32 malmö, sweden - tablet - minoxidil 10 mg - antihypertensives

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - minoxidil - solution - minoxidil 2 %w/v - minoxidil - minoxidil - androgenetic alopecia in females.

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - minoxidil - solution - minoxidil 5 % - minoxidil - minoxidil - androgenetic alopecia in males .

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

asumed biotech sdn. bhd. - minoxidil -

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - minoxidil, quantity: 50 mg/ml - application - excipient ingredients: propylene glycol; ethanol - regaine (minoxidil) topical solution 2% and 5% is indicated for the treatment of androgenetic alopecia (common baldness) in healthy adult males and females.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

mitsubishi tanabe pharma corporation - aluminoparaaminosalicylate calcium hydrate - white to grayish brown granules